http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
- 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
- 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
RISS 인기검색어
- 검색키워드
- 저자 : Edip (검색결과 5 건)
- 무료
- 기관 내 무료
- 유료
-
-
Behavior and design of stainless steel tubular member welded end connections
Guven Kiymaz,Edip Seckin 국제구조공학회 2014 Steel and Composite Structures, An International J Vol.17 No.3
Among the various alternatives to make a steel tubular member connection, making a slotted and gusset plate welded connection is one of the most frequently preferred alternatives. This type of connection is essentially an end connection that is made by slotting the tube longitudinally, inserting the gusset plate and then placing longitudinal fillet welds at the tube-to-plate interface. In this paper an experimental study on the behaviour of such connections in stainless steel is presented. 24 specimens were tested under concentrically applied axial tensile forces for varying tube-to-gusset plate weld lengths. Both circular and box section members were considered in the test program. Load-deformation curves were obtained and comparisons were made in terms of strength and ductility. The results obtained from the study were then critically examined and compared with currently available design guidance for slotted gusset plate welded tubular end connections. It is noted that no specific rules exist in international specifications on structural stainless steel which cover the design of such connections. Therefore, the results of this study are compared with the existing design rules for carbon steel.
-
Updates on Prevention of Hemorrhagic and Lacunar Strokes
Hsin-Hsi Tsai,Jong S. Kim,Eric Jouvent,M. Edip Gurol 대한뇌졸중학회 2018 Journal of stroke Vol.20 No.2
Intracerebral hemorrhage (ICH) and lacunar infarction (LI) are the major acute clinical manifestations of cerebral small vessel diseases (cSVDs). Hypertensive small vessel disease, cerebral amyloid angiopathy, and hereditary causes, such as Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL), constitute the three common cSVD categories. Diagnosing the underlying vascular pathology in these patients is important because the risk and types of recurrent strokes show significant differences. Recent advances in our understanding of the cSVD-related radiological markers have improved our ability to stratify ICH risk in individual patients, which helps guide antithrombotic decisions. There are general goodpractice measures for stroke prevention in patients with cSVD, such as optimal blood pressure and glycemic control, while individualized measures tailored for particular patients are often needed. Antithrombotic combinations and anticoagulants should be avoided in cSVD treatment, as they increase the risk of potentially fatal ICH without necessarily lowering LI risk in these patients. Even when indicated for a concurrent pathology, such as nonvalvular atrial fibrillation, nonpharmacological approaches should be considered in the presence of cSVD. More data are emerging regarding the presentation, clinical course, and diagnostic markers of hereditary cSVD, allowing accurate diagnosis, and therefore, guiding management of symptomatic patients. When suspicion for asymptomatic hereditary cSVD exists, the pros and cons of prescribing genetic testing should be discussed in detail in the absence of any curative treatment. Recent data regarding diagnosis, risk stratification, and specific preventive approaches for both sporadic and hereditary cSVDs are discussed in this review article.
-
Updates on Prevention of Cardioembolic Strokes
Topcuoglu, Mehmet Akif,Liu, Liping,Kim, Dong-Eog,Gurol, M. Edip Korean Stroke Society 2018 Journal of stroke Vol.20 No.2
<P>Cardiac embolism continues to be a leading etiology of ischemic strokes worldwide. Although pathologies that result in cardioembolism have not changed over the past decade, there have been significant advances in the treatment and stroke prevention methods for these conditions. Atrial fibrillation remains the prototypical cause of cardioembolic strokes. The availability of new long-term monitoring devices for atrial fibrillation detection such as insertable cardiac monitors has allowed accurate detection of this leading cause of cardioembolism. The non-vitamin K antagonist oral anticoagulants have improved our ability to prevent strokes for many patients with non-valvular atrial fibrillation (NVAF). Advances in left atrial appendage closure and the U.S. Food and Drug Administration approval of the WATCHMAN (Boston Scientific) device for stroke prevention in NVAF patients who have an appropriate rationale for a nonpharmacological alternative, have revolutionized the field and provided a viable option for patients at higher hemorrhagic risk. The role of patent foramen ovale closure for secondary prevention in selected patients experiencing cryptogenic ischemic strokes at a relatively young age has become clearer thanks to the very recent publication of long-term outcomes from three major studies. Advances in the management of infective endocarditis, heart failure, valvular diseases, and coronary artery disease have significantly changed the management of such patients, but have also revealed new concerns related to assessment of ischemic versus hemorrhagic risk in the setting of antithrombotic use. The current review article aims to discuss these advances especially as they pertain to the stroke neurology practice.</P>
-
연관 검색어 추천
이 검색어로 많이 본 자료
활용도 높은 자료
